Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

Aim. To assess the prognostic value of the mutation of DNA methylation genes, SF3B1, and TP53 in patients with myelodysplastic syndrome (MDS). Materials & Methods. Out of 35 MDS patients included into the trial 2 had multilineage dysplasia, 13 with excess blasts-I, 19 with excess blasts-II, an...

Full description

Bibliographic Details
Main Authors: NYu Tsvetkov, EV Morozova, IM Barkhatov, IS Moiseev, MV Barabanshchikova, AV Tishkov, DS Bug, NV Petukhova, EA Izmailova, SN Bondarenko, BV Afanasyev
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2019-03-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
myelodysplastic syndrome
molecular markers
mutations
next-generation sequencing
prognosis
Online Access: http://bloodjournal.ru/wp-content/uploads/2020/03/7.pdf

Internet

http://bloodjournal.ru/wp-content/uploads/2020/03/7.pdf

Similar Items